IMCR
Immunocore Holdings Ltd
30.30$
-1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.8 | -13 | -4.6 | 23 | 21 | -14 | 0.4 | 26 | -4.5 | -33 | -14 | -5.5 | -56 | |
| 1.4 | 0.2 | 1.0 | 1.0 | 1.0 | 1.2 | 0.9 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 3.6 | |
| 8.2 | 15 | 9.0 | 10 | 6.6 | 8.7 | 9.5 | 10 | 9.8 | 8.3 | 6.3 | 16 | 40 | |
| -2.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.7 | -4.5 | 8.1 | 27 | -35 | -8.2 | -7.6 | 27 | -1.3 | -20 | -30 | 8.5 | -43 | |
| 0.6 | 0.6 | 0.4 | 0.3 | 0.8 | 3.6 | 0.3 | 0.4 | 0.7 | 2.9 | 1.8 | 0.8 | 6.2 | |
| -1.8 | 0.6 | -0.4 | -350 | -0.8 | -3.5 | 9.7 | -30 | 5.3 | -0.9 | 4.2 | -0.8 | 7.8 | |
| 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.3 | – | – | – | 0.0 | -50 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 8.4 | 6.1 | 396 | -0.5 | 0.2 | -52 | 2.6 | 3.7 | 1.9 | 4.3 | 0.7 | 16 | 23 | |
| 7.4 | -1.3 | 390 | -328 | 33 | -82 | 21 | 11 | 10 | -31 | -15 | 16 | -20 | |
| 7.2 | -14 | -5.0 | 23 | 20 | -18 | 0.1 | 26 | -5.2 | -36 | -16 | -6.3 | -63 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.